Positioning Biobanking Assets for Maximum Value
As therapies and assays continue to migrate towards precision medicine, so too must the traditional biobanking model, which is a key component in the supply of both physical samples and the data necessary to achieve patient-specific treatments. As precision medicine grows, so, too, does demand for biobanking services, offering both strategic and financial investors a significant opportunity for value creation.
In this white paper, learn how to evaluate biobank platforms and develop growth strategies that leverage the market shift towards precision medicine.
- Components of the Biobanking Value Continuum
- The two main pathways from biobanking to precision medicine
- Case study: Traditional Biobanking Broker Platform